Latest headlines
AstraZeneca PLC News
The latest AstraZeneca PLC (AZN) news, aggregated as it breaks. News moves sentiment and sentiment moves price, so read these AZN headlines next to the live AstraZeneca PLC Fear and Greed Index.
Latest AstraZeneca PLC Headlines52
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
prnewswire.com · Jul 30, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
globenewswire.com · Jul 28, 2026
AstraZeneca Cancer Drug Targets Up to $5 Billion in Sales
gurufocus.com · Jul 28, 2026
AstraZeneca's drug pipeine is splitting opinion among City analysts
proactiveinvestors.co.uk · Jul 28, 2026
AstraZeneca PLC (AZN) Q2 2026 Earnings Call Transcript
seekingalpha.com · Jul 27, 2026
AZN Q2 Earnings and Sales Beat, Key Drugs Offset Generic Pressure
zacks.com · Jul 27, 2026
AstraZeneca's $2.63 Earnings Beat Supports $80 Billion Revenue Target
gurufocus.com · Jul 27, 2026
AstraZeneca: Q2 2026 Results Were All Right, But Farxiga Poses Risks
seekingalpha.com · Jul 27, 2026
Astrazeneca (AZN) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
zacks.com · Jul 27, 2026
Dow Jumps Over 400 Points; AstraZeneca Shares Rise After Q2 Earnings
benzinga.com · Jul 27, 2026
Astrazeneca Q2 Earnings Call Highlights
marketbeat.com · Jul 27, 2026
AstraZeneca drug prices evolving in response to Trump policy, executive says
reuters.com · Jul 27, 2026
AstraZeneca results: H1 and Q2 2026
businesswire.com · Jul 27, 2026
AstraZeneca shares climbs as full-year outlook reiterated despite recent trial failure - UPDATE
proactiveinvestors.com · Jul 27, 2026
AstraZeneca's rare disease drug misses main goal in late-stage trial
reuters.com · Jul 27, 2026
AstraZeneca earnings beat forecasts despite slight revenue miss
proactiveinvestors.co.uk · Jul 27, 2026
AstraZeneca Posts Sales Growth on Oncology Strength
wsj.com · Jul 27, 2026
AstraZeneca beats second-quarter profit expectations, holds outlook
reuters.com · Jul 27, 2026
EU Clears AZN's Etcamah Combo for First-Line ER-Positive Breast Cancer
zacks.com · Jul 24, 2026
FTSE 100 shares to watch: Lloyds, Barclays, IAG, NatWest, GSK, AstraZeneca
invezz.com · Jul 24, 2026
AstraZeneca 'magic' faces rare test after trial failure, share slide
reuters.com · Jul 24, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
prnewswire.com · Jul 23, 2026
AstraZeneca Wins EU Approval for Breast-Cancer Drug as U.S. Review Continues
wsj.com · Jul 23, 2026
AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law Firm
gurufocus.com · Jul 22, 2026
AZN Investors Have Opportunity to Join AstraZeneca PLC Fraud Investigation with the Schall Law Firm
businesswire.com · Jul 22, 2026
Jefferies says September lung data can offset AstraZeneca trial failure
proactiveinvestors.com · Jul 22, 2026
Jefferies says September lung data can offset AstraZeneca trial failure
proactiveinvestors.co.uk · Jul 22, 2026
Stay Ahead of the Game With Astrazeneca (AZN) Q2 Earnings: Wall Street's Insights on Key Metrics
zacks.com · Jul 22, 2026
Biotech's takeover boom may be running out of buyers
proactiveinvestors.co.uk · Jul 22, 2026
Royalty Pharma acquires royalty interest in AstraZeneca's cliramitug for up to $425 million from Neurimmune
globenewswire.com · Jul 22, 2026
These major drug stocks rally after Trump's zero tariff announcement
finbold.com · Jul 22, 2026
Varon Corp expands Ballislife HYDRO into Canada through Shoot 360 partnership
proactiveinvestors.com · Jul 22, 2026
Aftermath Silver begins drilling at Berenguela copper target and Chile's Challacollo project
proactiveinvestors.com · Jul 22, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of AstraZeneca PLC- AZN
globenewswire.com · Jul 21, 2026
Astrazeneca (AZN) Falls More Steeply Than Broader Market: What Investors Need to Know
zacks.com · Jul 20, 2026
AI Bubble Risks Make Dividend Stocks Attractive Again
seekingalpha.com · Jul 18, 2026
AstraZeneca (AZN) Securities Investigation Notice - Levi & Korsinsky
prnewswire.com · Jul 16, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
prnewswire.com · Jul 16, 2026
AZN Inks Deal With Dizal to In-License Rights to Lung Cancer Drug
zacks.com · Jul 15, 2026
AstraZeneca's Oncology Engine Keeps Running Despite Wainua Setback
seekingalpha.com · Jul 15, 2026
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN
globenewswire.com · Jul 14, 2026
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving AstraZeneca (AZN)
globenewswire.com · Jul 14, 2026
Solis Minerals launches lithium drilling across 800-metre Mandacaru corridor in Brazil
proactiveinvestors.com · Jul 14, 2026
AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill
proactiveinvestors.com · Jul 14, 2026
ACG Metals beats oxide production target as gold price surges 64%
proactiveinvestors.com · Jul 14, 2026
AstraZeneca to pay up to $1.5bn for global rights to lung cancer pill
proactiveinvestors.co.uk · Jul 14, 2026
AstraZeneca Enters Exclusive License Deal For Lung Cancer Drug Zegfrovy For Up to $1.5 Billion
wsj.com · Jul 14, 2026
AstraZeneca to license lung cancer drug from China's Dizal Pharmaceutical
reuters.com · Jul 14, 2026
The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions
marketbeat.com · Jul 13, 2026
AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN)
gurufocus.com · Jul 13, 2026
AZN Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AstraZeneca (AZN)
businesswire.com · Jul 13, 2026
HSBC downgrades AstraZeneca after key trial failure
proactiveinvestors.co.uk · Jul 13, 2026
Why Is AstraZeneca PLC Up or Down Today?
When AstraZeneca PLC (AZN) moves sharply, the reason is almost always in the headlines above. Earnings, guidance, analyst upgrades and downgrades, product news and macro data are the usual drivers of a AZN move on the day. The feed shows what broke and when, and the sentiment tag on each story shows whether the coverage skews positive or negative, so you can see at a glance why AstraZeneca PLC is up or down today.
How AstraZeneca PLC News Affects the Price
News does not move the AstraZeneca PLC (AZN) price directly, it moves sentiment, and sentiment moves price. A run of negative headlines pulls the AstraZeneca PLC Fear and Greed Index toward fear, while positive coverage pushes it toward greed, often before the price has fully reacted. A surprise story usually shows up first as a spike in AstraZeneca PLC trading volume. That is the chain to watch: headline, sentiment, volume, then the AZN price.
Trade the AstraZeneca PLC News With Sentiment
Headlines tell you what happened; the Fear and Greed Index tells you how the crowd is reacting. Watch AstraZeneca PLC trading volume spike on a big story, check the AstraZeneca PLC price history for context, follow the live AZN price, see the AstraZeneca PLC price prediction, and read the AstraZeneca PLC Fear and Greed Index for mood.
How do you feel about AstraZeneca PLC?
1DFrequently asked questions
Why is AstraZeneca PLC up or down today?
What is the latest AstraZeneca PLC news?
Where does AstraZeneca PLC news come from?
How often is AstraZeneca PLC news updated?
How does AstraZeneca PLC news relate to its Fear and Greed Index?
Headlines are aggregated from third-party sources and link to the original publishers. CFGI does not author or endorse them.
About CFGI
The per-asset sentiment record.
CFGI is a market sentiment data company that scores crowd emotion from 0 to 100 across crypto and stock markets. Crypto readings cover the whole market and hundreds of individual assets across 15-minute, 1-hour, 4-hour and daily views. The stock index gives a live daily reading for wider stock market sentiment.
Every CFGI score is built from 10 indicators: price, volatility, volume, impulse, technical analysis, social media, dominance, search interest, whale movements and order book pressure. The same data powers our API, alerts and embeddable widgets.